BCYC — BICYCLE THERAPEUTICS PLC
—
Nasdaq ·
Health Care ·
Pharmaceuticals ·
CIK 1761612 ·
Last close
$4.57
Market Cap
$230.21M
52W High
$5.76
52W Low
$4.24
ADV30
377,019
Next earnings
—
Quarterly Fundamentals
Revenues vs Net Income (last 4 Q)
Assets vs Liabilities (last 4 Q)
| Period | Revenues | GrossProfit | OpIncome | NetIncome | Assets | Cash | Liabilities |
|---|---|---|---|---|---|---|---|
| Mar 2026 | 887,000 | — | -65,589,000 | -60,825,000 | 652,396,000 | 559,474,000 | 98,076,000 |
| Dec 2025 | 47,955,000 | — | -24,657,000 | -20,154,000 | 717,597,000 | 628,110,000 | 107,620,000 |
| Sep 2025 | 11,734,000 | — | -65,709,000 | -59,100,000 | 763,954,000 | 648,325,000 | 145,475,000 |
| Jun 2025 | 2,920,000 | — | -87,347,000 | -78,952,000 | 832,184,000 | 721,451,000 | 163,269,000 |
Cashflow TTM (yfinance, fills SEC gap)
Operating CF
$-229,230,000
Investing CF
$-2,459,000
Financing CF
$-144,000
CapEx
$-2,459,000
Dividends Paid
—
Buybacks
—
EPS Diluted TTM
$-3.15
As of
2026-05-10
Balance + Analyst (yfinance extras)
Retained Earnings
$-960,576,000
Inventory
—
Receivables
$40,917,000
ST Investments
—
EBIT TTM
$-217,417,000
Pretax Income TTM
$-217,620,000
Interest Exp TTM
$203,000
Analysts
9
Yahoo Snapshot (yfinance, live)
Total Revenue
$72,586,000
EBITDA
$-236,443,008
Free Cash Flow
$-121,572,376
Enterprise Value
$-282,240,832
Total Cash
$628,110,016
Total Debt
$16,852,000
Shares Out
50,373,281
Trailing EPS
$-3.15
Book Value
$8.79
ROE
-31.2%
ROA
-18.1%
Div Yield
—
Annual Trend (SEC EDGAR, last 4y)
Revenues vs Net Income (last 4y)
| FY end | Revenues | OpIncome | NetIncome | Assets | Liabilities | Equity | OCF |
|---|---|---|---|---|---|---|---|
| Dec 2025 | 72,586,000 | -247,718,000 | -218,960,000 | 717,597,000 | 107,620,000 | — | -249,675,000 |
| Dec 2024 | 35,275,000 | -209,153,000 | -169,031,000 | 956,868,000 | 163,808,000 | — | -164,724,000 |
| Dec 2023 | 26,976,000 | -189,946,000 | -180,664,000 | 595,344,000 | 224,412,000 | — | -60,628,000 |
| Dec 2022 | 14,463,000 | -116,653,000 | -112,717,000 | 410,609,000 | 139,826,000 | — | -86,111,000 |
TTM Snapshot
Revenues TTM
—
NetIncome TTM
—
OpCashFlow TTM
—
Assets (Latest)
—
Forward EPS
$-2.13
Peers — same industry
| Ticker | Name | Market Cap | Last | Daily % |
|---|---|---|---|---|
| CNTN | Canton Strategic Holdings, Inc. | $229.66M | $3.29 | — |
| WHWK | Whitehawk Therapeutics, Inc. | $235.89M | $4.77 | — |
| RNA | Atrium Therapeutics, Inc. | $223.40M | $13.06 | — |
| KROS | Keros Therapeutics, Inc. | $222.26M | $11.23 | — |
| HELP | CYBIN INC. | $221.03M | $4.43 | — |
News headlines (Yahoo Finance, 1h cache)
European Equities Traded in the US as American Depositary Receipts Edge Higher in Friday Trading
2026-05-22 15:06 · Yahoo
Bicycle Therapeutics to Present Initial Duravelo-2 Data at 2026 ASCO Annual Meeting
2026-05-21 21:00 · Yahoo
European Equities Traded in the US as American Depositary Receipts Heading Lower in Thursday Trading
2026-05-07 15:10 · Yahoo
European Equities Traded in the US as American Depositary Receipts Flat in Friday Trading; Gain 1.3% for Week
2026-05-01 15:10 · Yahoo
European Equities Traded in the US as American Depositary Receipts Rise in Thursday Trading
2026-04-30 15:06 · Yahoo
Bicycle Therapeutics Reports Recent Business Progress and First Quarter 2026 Financial Results
2026-04-30 11:00 · Yahoo
Bicycle Therapeutics Announces Oral and Poster Presentations at the 2026 ASCO Annual Meeting
2026-04-21 14:31 · Yahoo
Bicycle Therapeutics Provides Update on Nuzefatide Pevedotin and EphA2 Pipeline at the AACR Annual Meeting 2026
2026-04-20 11:00 · Yahoo
Morgan Stanley Updates Bicycle Therapeutics plc (BCYC) Outlook Amid Pipeline Refocus
2026-04-17 13:58 · Yahoo
European Equities Traded in the US as American Depositary Receipts Declining in Thursday Trading
2026-04-16 15:05 · Yahoo
Recent Insider Activity
No insider activity indexed for this ticker.